ATE322898T1 - Inhibitoren von mycobakterien - Google Patents

Inhibitoren von mycobakterien

Info

Publication number
ATE322898T1
ATE322898T1 AT99957018T AT99957018T ATE322898T1 AT E322898 T1 ATE322898 T1 AT E322898T1 AT 99957018 T AT99957018 T AT 99957018T AT 99957018 T AT99957018 T AT 99957018T AT E322898 T1 ATE322898 T1 AT E322898T1
Authority
AT
Austria
Prior art keywords
mycobacteria
inhibitors
treatment
certain
provides
Prior art date
Application number
AT99957018T
Other languages
English (en)
Inventor
Meenakshi Balganesh
Kantharaj Ethirajulu
Babita Singh Ganguly
Ramachandran Janakiraman
Parvinder Kaur
Rangarao Kajipalya
Santosh Nandan
Ramanujulu Pondi Murugappan
Narayanan Ramamurthy
Balasubramanian Venkataraman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802118A external-priority patent/SE9802118D0/xx
Application filed filed Critical
Application granted granted Critical
Publication of ATE322898T1 publication Critical patent/ATE322898T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99957018T 1998-05-05 1999-05-03 Inhibitoren von mycobakterien ATE322898T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN969MA1998 1998-05-05
SE9802118A SE9802118D0 (sv) 1998-06-15 1998-06-15 Mycobacterial inhibitors

Publications (1)

Publication Number Publication Date
ATE322898T1 true ATE322898T1 (de) 2006-04-15

Family

ID=26324850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957018T ATE322898T1 (de) 1998-05-05 1999-05-03 Inhibitoren von mycobakterien

Country Status (14)

Country Link
US (1) US6476053B1 (de)
EP (1) EP1075261B1 (de)
JP (1) JP2002518324A (de)
KR (1) KR20010043322A (de)
CN (1) CN1201735C (de)
AT (1) ATE322898T1 (de)
AU (1) AU739140B2 (de)
BR (1) BR9910185A (de)
CA (1) CA2330667A1 (de)
DE (1) DE69930844T2 (de)
IL (1) IL139144A0 (de)
NO (1) NO20005548L (de)
NZ (1) NZ507620A (de)
WO (1) WO1999065483A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2789114C (en) 2001-11-01 2014-03-25 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
CA2619262A1 (en) * 2005-08-19 2007-02-22 Astrazeneca Ab Pyrazolone derivatives for the treatment of tuberculosis
GB0520368D0 (en) * 2005-10-06 2005-11-16 Univ Aston Antibacterial pyrrols
US8796472B2 (en) 2008-12-04 2014-08-05 Basf Se Mixtures of itaconic acid or itaconic acid derivatives and primary amines for producing 1,3- and 1,4-alkyl methyl pyrrolidones
PL3393530T3 (pl) * 2015-12-23 2022-12-05 Henkel Ag & Co. Kgaa Płyn do obróbki metali
CN107033060B (zh) * 2017-05-04 2020-01-14 浙江工业大学 一种n-取代顺丁烯二酰亚胺类化合物及其制备与抗菌应用
US11890364B2 (en) 2017-12-01 2024-02-06 Good T Cells, Inc. Composition for prevention or treatment of hair loss

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883342A (en) * 1973-04-13 1975-05-13 Akzona Inc Plant growth regulators

Also Published As

Publication number Publication date
KR20010043322A (ko) 2001-05-25
NZ507620A (en) 2003-05-30
NO20005548D0 (no) 2000-11-03
EP1075261B1 (de) 2006-04-12
NO20005548L (no) 2000-12-04
CN1201735C (zh) 2005-05-18
WO1999065483A1 (en) 1999-12-23
CN1308532A (zh) 2001-08-15
IL139144A0 (en) 2001-11-25
JP2002518324A (ja) 2002-06-25
AU4304199A (en) 2000-01-05
CA2330667A1 (en) 1999-12-23
DE69930844T2 (de) 2006-12-28
EP1075261A1 (de) 2001-02-14
DE69930844D1 (de) 2006-05-24
AU739140B2 (en) 2001-10-04
US6476053B1 (en) 2002-11-05
BR9910185A (pt) 2001-01-09

Similar Documents

Publication Publication Date Title
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
ID25853A (id) Penghambat saluran kalium
EA199800667A1 (ru) Новые фенантридины
DE69905170T2 (de) Thiazolopyrimidinderivate
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
DE60010098D1 (de) 28-epirapaloge
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
EA199900373A2 (ru) Фармацевтические композиции
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
ATE461217T1 (de) Glp-1-verbindungen
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
TR200103216T2 (tr) Pirimidinon bileşimleri
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE60037813D1 (de) Antworten auf hypoxia modifizieren
SE0301650D0 (sv) Novel compounds
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DK1051187T3 (da) Behandling af follikulære lymfomer ved anvendelse af inhibitorer af lymfotoxin(LT)-syntesevejen
ATE322898T1 (de) Inhibitoren von mycobakterien
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties